Investigation Effectiveness Drives Human Performance Excellence

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-11-15-2016
Volume 2016 eBook
Issue 3
Pages: s38–s47

Are investigations supporting or hindering performance excellence?

Every biopharm company conducts investigations for undesirable outcomes related to safety, quality, and reliability of product and processes. The question is to what degree do these investigations support or hinder performance excellence?

A sub-team that was formed as part of the BioPhorum Operations Group (BPOG) human performance workstream sought to answer this question. The findings suggest that biopharm is behind other industries with respect to investigation best practices.

This article provides a pathway for the industry to improve its investigations, and in so doing, improve overall organizational learning and performance.

Download Pharmaceutical Technology’s 

2016 Quality Throughout the Supply Chain eBook

.

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development